Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis

Yongqiang Li(Henan Provincial People's Hospital), Lixia Wang(Henan Provincial People's Hospital)
Experimental and Therapeutic Medicine
October 31, 2017
Cited by 19


Related Papers